Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
   
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Pathways
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Research News
 
α-Synuclein’s Day Job: To Chaperone SNARE Complexes?
2 September 2010. To release neurotransmitters, nerve terminals must repeatedly break down and rebuild specialized protein complexes, and the fidelity of this process may rely on α-synuclein...
 
ALS—A Polyglutamine Disease? Mid-length Repeats Boost Risk
28 August 2010. Researchers have mediated a merger of sorts between two distinct neurodegenerative conditions—ALS and (SCA)—and the proteins that cause them...
 
Insulin Resistance Correlates With Plaque, But Not Tangle, Pathology
28 August 2010. Having diabetes seems to drive up risk for dementia, including Alzheimer disease, but the jury has been out as to how this occurs...
 
Common Ground: Is Aβ the Foundation for Multiple Dementias?
27 August 2010. The majority of patients with Parkinson disease eventually develop dementia, but what pathology underlies this decline?...
 
GO TO ALL RESEARCH NEWS  
 
 
In the spotlight

Microdissection, Microarrays: Analyzing Selective Cell Vulnerability
As Tolstoy wrote in Anna Karenina, “Happy families are all alike; every unhappy family is unhappy in its own way.” The same might be said of the brain. Normal brains look and behave similarly, but those affected by different neurodegenerative diseases are unique, since each disease targets a select subset of cells. This selective cell
vulnerability presents a puzzle, particularly in the case of disease caused by inherited mutations: If the mutation is present in every cell in the body, what leads some neurons to resist its effects while others degenerate?

Analyzing differences between affected and unaffected cells might provide the answer. Increasingly, researchers have taken advantage of modern technology, such as laser capture microscopy to isolate individual cells and microarray analysis to compare their gene expression patterns. How are these types of analyses advancing our understanding of selective cell vulnerability?

Join us on Tuesday, 14 September 2010 at noon, U.S. Eastern Daylight Saving Time, for a Webinar led by Eva Hedlund of the Karolinska Institute in Stockholm, Sweden. Hedlund will discuss her latest results on ALS, and Chee-Yeun Chung of MIT’s Whitehead Institute will share her data on selective cell vulnerability in Parkinson disease. Rickard Sandberg, also from the Karolinska Institute, will present a new technique—RNA deep sequencing—that allows him to discover not only which mRNAs are present in tissues, cell lines, or single cells, but which splice forms they represent. Joining these presenters for a panel discussion are Stanislav Karsten of the University of California in Los Angeles, and Stephen Ginsberg of the Nathan Kline Institute in Orangeburg, New York. Image credit: Wikicommons/Guillaume Paumier

 
 
What's New

Jobs - Posted 2 September 2010
Director of the Division of Neuroscience, National Institute on Aging: Department of Health and Human Services, National Institutes of Health, Bethesda, Maryland.
 
Comments - Posted 1 September 2010
Read remarks by Terrence Town about Boyd TD et al.
PAPER: GM-CSF Upregulated in Rheumatoid Arthritis Reverses Cognitive Impairment and Amyloidosis in Alzheimer Mice.
 
Comments - Posted 1 September 2010
Read remarks by Niklas Mattsson about Siderowf A et al.
PAPER: CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease.
 
Comments - Posted 1 September 2010
Read remarks by Elliott Mufson
NEWS: Anti-Aβ Oligomer Headed for Phase 3 Clinical Trial
 
Comments - Posted 1 September 2010
Read remarks by Torleif Härd about Zhuang W et al.
PAPER: Discriminating early stage A{beta}42 monomer structures using chirality-induced 2DIR spectroscopy in a simulation study.
 
Comments - Posted 1 September 2010
Read remarks by Giampaolo Merlini, Laura Obici about Bugiani O et al.
PAPER: Hereditary cerebral hemorrhage with amyloidosis associated with the E693K mutation of APP.
 
Comments - Posted 1 September 2010
Read remarks by Hugo Geerts
NEWS: Lilly Halts IDENTITY Trials as Patients Worsen on Secretase Inhibitor
 
Comments - Posted 1 September 2010
Read remarks by Jochen Herms
NEWS: Lilly Halts IDENTITY Trials as Patients Worsen on Secretase Inhibitor

SEE MORE  
Print this page
Email this page
Alzforum News
Follow on Twitter
Text size
Share & Bookmark
Forum Calendar

Join us on Tuesday, 14 September 2010 at noon, U.S. Eastern Daylight Saving Time, for a Webinar, Microdissection and Microarrays: Analyzing Selective Cell Vulnerability.

Check out our most recent Webinar/Live Discussion: Untapped Resource? New Study to Boost Acceptance of CSF Analysis, held 5 August 2010.

Check out our Webinar/Live Discussion: Together at Last, Top Five Biomarkers Model Stages of AD, held 21 January 2010.


Live NIH Videocasts

Stem Cell Seminar
Tuesday, September 14, 2010, 11:00 a.m.

Metabolomics Technologies in Translational Research
Friday, September 17, 2010, 8:00 a.m.

Clinical Trials and Translational Research Advisory Committee (CTAC) Meeting
Tuesday, September 21, 2010, 8:00 a.m.

AlzRisk: An AD Epidemiology Database
The AlzRisk Epidemiology Database provides a publicly available collection of published studies on the impact of putative environmental risk factors and protective factors related to Alzheimer disease in longitudinal cohort studies.
AlzGene
MSGene
PDGene
SZGene
An up-to-date collection of all published genetic association studies.
Alzheimer's Research & Therapy

Announcing Alzheimer's Research & Therapy, a new online peer-reviewed journal which publishes open access research articles of outstanding quality in Alzheimer's research.
Alzheimer's Research & Therapy
Topics in Neurodegeneration
Download Powerpoint Presentations created by top experts in neurodegenerative disease research. Available for educational or personal use. Edited by Daniel M. Michaelson, PhD, and Tobias Hartmann, PhD.

ADDF

The Drug Development Company Database and Tutorial represent the collaborative efforts of the Alzheimer's Drug Discovery Foundation (ADDF) and the Alzheimer Research Forum. Our thanks to ADDF, Jens Eckstein, and the Advisory Board for bringing this project to fruition.
Polls
 
Should the FDA be allowed to use data from overseas clinical trials?

Absolutely, we are running out of viable subjects in the U.S.
 9
 
Yes, so long as the data is reliable
 31
 
No, the trials are not as rigorous
 3
 
No, the data should be repeated in the U.S.
 5
 
No, the drug sponsors are just trying to cut corners
 3
 
Responses: 51
 
 
 
 
 
Archived Polls
 
Copyright © 1996-2010 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad